"Renin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19.
Descriptor ID |
D012083
|
MeSH Number(s) |
D08.811.277.656.074.500.780 D08.811.277.656.300.048.780 D08.811.277.656.837.750
|
Concept/Terms |
Renin- Renin
- Angiotensin-Forming Enzyme
- Angiotensin Forming Enzyme
- Angiotensinogenase
Prorenin- Prorenin
- Inactive Renin
- Renin, Inactive
- Big Renin
- Renin, Big
- Cryorenin
|
Below are MeSH descriptors whose meaning is more general than "Renin".
Below are MeSH descriptors whose meaning is more specific than "Renin".
This graph shows the total number of publications written about "Renin" by people in this website by year, and whether "Renin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2017 | 2 | 7 | 9 |
2018 | 3 | 3 | 6 |
2019 | 3 | 2 | 5 |
2020 | 0 | 2 | 2 |
2021 | 1 | 4 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Renin" by people in Profiles.
-
Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? Front Endocrinol (Lausanne). 2021; 12:665134.
-
Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19. Med Hypotheses. 2021 Jul; 152:110609.
-
Effect of Reducing Sedentary Behavior on Blood Pressure (RESET BP): Rationale, design, and methods. Contemp Clin Trials. 2021 07; 106:106428.
-
Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19. Eur J Endocrinol. 2021 Apr; 184(4):543-552.
-
Renin-angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report. Crit Care. 2021 03 01; 25(1):91.
-
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. Eur J Heart Fail. 2021 03; 23(3):486-488.
-
Associastion of In-hospital Use of Statins, Aspirin, and Renin-Angiotensin-Aldosterone Inhibitors with Mortality and ICU Admission Due to COVID-19. Adv Exp Med Biol. 2021; 1327:205-214.
-
Plasma renin activity has a complex prognostic role in patients with acute coronary syndromes. Int J Cardiol. 2021 04 15; 329:198-204.
-
Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study. Virology. 2021 02; 554:48-54.
-
The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients? Bioessays. 2021 03; 43(3):e2000112.